Mark Floyd appointed Chairman of the Board of Directors; Current Valencell CEO and Board Chair Michael Dering is retiring
Raleigh, N.C. – December 12, 2018 – Valencell, the leading innovator in wearable biometric sensor technology, today announced that Kent Novak has been named Chief Executive Officer. Novak was most recently Senior Vice President & General Manager, DLP Products, at Texas Instruments (TI). There he transformed the DLP Products organization to help drive significant growth in multiple new markets. In addition, Valencell has named Mark Floyd Board of Directors Chairman. Floyd is a venture partner at TDF Ventures, one of Valencell’s long-time investors, and has served as Chairman and CEO leading numerous public and private technology companies through acquisition and IPO.
Current Valencell CEO and Board Chair Michael Dering is retiring in December and will stay on in an advisory role through the transition.
“I couldn’t be more excited to join the team at Valencell and help the company build on its success to date,” said Kent Novak, Valencell Chief Executive Officer. “I was immediately impressed with the company’s tremendous mix of outstanding technology, top notch talent on the team, great customers and partners, and huge market opportunities at hand. I look forward to bringing my skills and experience to that mix to take the company to the next level of growth and value.”
“We’re very happy to be able to add two world-class executives to the Valencell team. Mark brings a vast range of executive and board leadership experience to the Valencell board and Kent has a fantastic track record of growth and development in the industry. I’m particularly excited about Kent’s experience growing TI’s DLP Products business which is directly relevant for Valencell because it parallels how we ‘breathe life’ into silicon technology across multiple markets, form factors and use cases,” said Dr. Steven LeBoeuf, President & Co-Founder of Valencell. “His leadership will also be extremely valuable in growing our relationship with strategic partners like Sonion and developing new strategic relationships.”
Dr. LeBoeuf added, “I’d also like to thank Michael Dering for his outstanding leadership in this company for the last four years. His contributions to Valencell’s growth and strategic value can’t be underestimated and for that we’re very grateful.”
Valencell produces the most accurate wearable biometric sensor systems in the world and provides this patent-protected technology to consumer electronics manufacturers, mobile device and accessory makers, medical device makers, sports and fitness brands and gaming companies for integration into their products. Protected by more than 70 granted patents and more than 100 patents pending, Valencell’s technology can be used in wearables and hearables for virtually anyone, anywhere, doing anything. Their technology is scalable to multiple form-factors such as earbuds, smartwatches, armbands and wrist devices and is currently integrated into more biometric wearable devices than any other technology provider in the world.